ARKG Investment Tracker
Source from：official website ARKG is an exchange-traded fund (ETF) managed by Cathie Wood, focusing on stocks related to the genomic revolution. The "ARK Genomic Revolution Fund Guru Tracker" is based on ARKG's daily disclosure reports, helping investors track its investment strategy.
0Follow
3175Followers
0Topic
0Badge
ARKG Investment Tracker position change: Increased position in Schrodinger Inc. by 16,230 shares, the number of shares held increased 0.72% compared to the previous period and now represents 2.91% of the total position.
ARKG Investment Tracker position change: Increased position in Tempus AI by 17,760 shares, the number of shares held increased 0.72% compared to the previous period and now represents 8.4% of the total position.
ARKG Investment Tracker position change: Increased position in Freenome, Inc. by 92,458 shares, the number of shares held increased 8.54% compared to the previous period and now represents 0.74% of the total position.
ARKG Investment Tracker position change: Increased position in Eli Lilly by 468 shares, the number of shares held increased 0.72% compared to the previous period and now represents 3.82% of the total position.
ARKG Investment Tracker position change: Increased position in Natera by 1,782 shares, the number of shares held increased 0.72% compared to the previous period and now represents 4.9% of the total position.
ARKG Investment Tracker position change: Increased position in Generate Biomedicines by 11,358 shares, the number of shares held increased 0.72% compared to the previous period and now represents 0.97% of the total position.
ARKG Investment Tracker position change: Decreased position in CareDx by 34,629 shares, the number of shares held decreased 2.81% compared to the previous period and now represents 3.89% of the total position.
ARKG Investment Tracker position change: Increased position in Ionis Pharmaceuticals by 6,300 shares, the number of shares held increased 0.72% compared to the previous period and now represents 1.85% of the total position.
ARKG Investment Tracker position change: Increased position in GeneDx Holdings by 3,720 shares, the number of shares held increased 0.72% compared to the previous period and now represents 1.68% of the total position.
ARKG Investment Tracker position change: Increased position in Twist Bioscience Corp by 8,334 shares, the number of shares held increased 0.72% compared to the previous period and now represents 8.75% of the total position.
ARKG Investment Tracker position change: Increased position in 10x Genomics, Inc. by 17,682 shares, the number of shares held increased 0.72% compared to the previous period and now represents 8.81% of the total position.
ARKG Investment Tracker position change: Increased position in Illumina by 2,670 shares, the number of shares held increased 0.72% compared to the previous period and now represents 5.03% of the total position.
ARKG Investment Tracker position change: Increased position in COMPASS Pathways plc by 35,292 shares, the number of shares held increased 0.72% compared to the previous period and now represents 2.73% of the total position.
ARKG Investment Tracker position change: Increased position in Nurix Therapeutics by 53,097 shares, the number of shares held increased 2.39% compared to the previous period and now represents 2.49% of the total position.
ARKG Investment Tracker position change: Increased position in Guardant Health Inc. by 4,350 shares, the number of shares held increased 0.72% compared to the previous period and now represents 4.9% of the total position.
ARKG Investment Tracker position change: Increased position in Adaptive Biotechnologies Corp by 13,194 shares, the number of shares held increased 0.72% compared to the previous period and now represents 2.31% of the total position.
ARKG Investment Tracker position change: Increased position in Veracyte by 11,226 shares, the number of shares held increased 0.72% compared to the previous period and now represents 3.36% of the total position.
ARKG Investment Tracker position change: Increased position in Kymera Therapeutics, Inc. by 4,365 shares, the number of shares held increased 4.49% compared to the previous period and now represents 0.54% of the total position.
ARKG Investment Tracker position change: Increased position in Prime Medicine, Inc. by 55,860 shares, the number of shares held increased 0.72% compared to the previous period and now represents 1.29% of the total position.
ARKG Investment Tracker position change: Increased position in Alamar Biosciences by 8,070 shares, the number of shares held increased 0.72% compared to the previous period and now represents 1.32% of the total position.
Go to Tiger App to see more news